In vitro antimicrobial activity of Shiva-11 against ocular pathogens

L Gunshefski1, M J Mannis, J S Cullor

  • 1Department of Ophthalmology, School of Medicine, University of California, Davis.

Cornea
|May 1, 1994
PubMed

Insights

A synthetic cecropin analog, Shiva-11, shows broad-spectrum antimicrobial activity against common ocular pathogens. This peptide demonstrates significant killing of bacteria and fungi, suggesting therapeutic potential for eye infections.

Area of Science:

  • Microbiology
  • Peptide Science
  • Ophthalmology

Background:

  • Cecropins are antimicrobial peptides from the cecropia moth with known efficacy against diverse pathogens.
  • Ocular infections pose a significant threat, necessitating novel therapeutic agents.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of the synthetic cecropin analog Shiva-11.
  • To assess Shiva-11's potential against key human clinical ocular pathogens.

Main Methods:

  • Shiva-11 was tested against Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Candida albicans.
  • Antimicrobial activity was assessed by exposing bacterial suspensions to varying concentrations of Shiva-11 at 37°C.
  • Colony counts were determined after 24-48 hours of incubation on nutrient agar.

Main Results:

  • Shiva-11 demonstrated a greater than 3-log reduction in all tested isolates within 60 minutes.
  • The compound exhibited broad-spectrum activity against gram-positive bacteria, gram-negative bacteria, and fungi.

Conclusions:

  • The synthetic cecropin analog Shiva-11 possesses potent in vitro antimicrobial activity.
  • Shiva-11 shows promise as a therapeutic agent for treating human clinical ocular infections.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...